Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
J Immunol ; 202(1): 105-118, 2019 01 01.
Artigo em Inglês | MEDLINE | ID: mdl-30504423

RESUMO

An integral component of the antiviral response, type I IFNs require regulation to modulate immune activation. We identify ß-arrestin 2 as a key modulator of type I IFN in primary human macrophages, an essential component of the innate immune response. ß-Arrestin 2 was selectively activated by CCL2/CCR2 signaling, which induced a decrease in IFN-α, but not IFN-ß expression. Small interfering RNA knockdown of ß-arrestin 2 demonstrated its role in IFNAR1 internalization, as well as STAT1 and IRF3 activation. As a result, cytokine responses were not propagated following HIV infection and TLR3 activation. However, remnants of IFN signaling remained intact, despite ß-arrestin 2 activation, as IFN-ß, IFN-γ, IFN-λ1, IRF7, TRAIL, and MxA expression were sustained. Similar effects of ß-arrestin 2 on IFN signaling occurred in hepatocytes, suggesting that arrestins may broadly modulate IFN responses in multiple cell types. In summary, we identify a novel role of ß-arrestin 2 as an integral regulator of type I IFN through its internalization of IFNAR1 and a subsequent selective loss of downstream IFN signaling.


Assuntos
Infecções por HIV/imunologia , HIV-1/fisiologia , Hepatócitos/fisiologia , Interferon-alfa/metabolismo , Macrófagos/imunologia , Receptor de Interferon alfa e beta/metabolismo , beta-Arrestina 2/metabolismo , Células Cultivadas , Quimiocina CCL2/metabolismo , Humanos , Imunidade Inata , Fator Regulador 3 de Interferon/genética , Fator Regulador 3 de Interferon/metabolismo , Interferon Tipo I/imunologia , Cultura Primária de Células , RNA Interferente Pequeno/genética , Receptores CCR2/metabolismo , Fator de Transcrição STAT1/genética , Fator de Transcrição STAT1/metabolismo , Transdução de Sinais , Receptor 3 Toll-Like/metabolismo , Ativação Transcricional , beta-Arrestina 2/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA